Clincosm LogoSign in Get a demo

Lymphoma, Mantle-Cell

Showing 26 - 45 of 45
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Mantle-cell, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Hairy Cell Trial run by the NHLBI (ON01910 Na)

Completed
  • Lymphoma, Mantle-cell
  • +4 more
  • ON01910 Na
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 30, 2019

Mantle Cell Lymphoma, Lymphoma, Mantle-Cell Trial in Worldwide (Lenalidomide, Investigators choice single agent)

Completed
Has Results
  • Mantle Cell Lymphoma
  • Lymphoma, Mantle-Cell
  • Brussel, Belgium
  • +96 more
Aug 13, 2019

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in Worldwide (Part 1 (Dose

Terminated
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +4 more
  • Part 1 (Dose Escalation): Duvortuxizumab
  • Part 2 (Dose Expansion): Duvortuxizumab
  • Detroit, Michigan
  • +19 more
Dec 19, 2018

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular Trial in Argentina, United States (ASN002 Dose

Terminated
  • Lymphoma, Large B-Cell, Diffuse
  • +20 more
  • ASN002 Dose Escalation
  • ASN002 RD
  • Tempe, Arizona
  • +13 more
Aug 13, 2018

Lymphoma, Mantle-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in Worldwide (Daratumumab)

Terminated
Has Results
  • Lymphoma, Mantle-Cell
  • +2 more
  • Duarte, California
  • +34 more
May 28, 2018

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial (Duvortuxizumab, Ibrutinib)

Withdrawn
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +3 more
  • (no location specified)
Nov 22, 2017

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in United States (SGN-CD19A)

Completed
  • Burkitt Lymphoma
  • +4 more
  • Birmingham, Alabama
  • +5 more
Oct 17, 2017

Lymphoma, Mantle-Cell Trial in United States (Copanlisib (BAY80-6946))

Terminated
  • Lymphoma, Mantle-Cell
  • Copanlisib (BAY80-6946)
  • Baltimore, Maryland
  • +4 more
Sep 29, 2017

Lymphoma, Mantle-Cell Trial in Worldwide (Rituximab, Cyclophosphamide, Doxorubicin)

Unknown status
  • Lymphoma, Mantle-Cell
  • Praha, Czech Republic
  • +6 more
Mar 6, 2017

Lenalidomide in Mantle Cell Lymphoma Who Failed Ibrutinib

Completed
  • Lymphoma, Mantle-Cell
    • Phoenix, Arizona
    • +13 more
    Jan 25, 2017

    Lymphoma, Mantle-cell Trial in Japan (Ibrutinib)

    Completed
    • Lymphoma, Mantle-cell
    • Fukuoka, Japan
    • +7 more
    Jan 23, 2017

    GVHD, MDS, Leukemia Trial run by the NHLBI (RFT5-SMPT-dgA, Isolex system)

    Completed
    Has Results
    • Graft vs Host Disease
    • +9 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Sep 21, 2016

    Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With

    Completed
    Has Results
    • Carcinoma, Renal Cell
    • Lymphoma, Mantle-Cell
    • Temsirolimus (Non-Interventional Study)
    • Oviedo, Asturias, Spain
    • +15 more
    Mar 25, 2016

    Lymphoma, Mantle-Cell Trial in Boston, New York, Philadelphia (PD-0332991)

    Completed
    Has Results
    • Lymphoma, Mantle-Cell
    • Boston, Massachusetts
    • +5 more
    Oct 6, 2015

    Acute Myeloid Leukemia, Myelodysplasia, Acute Lymphoblastic Leukemia Trial in San Francisco (umbilical cord stem cells)

    Terminated
    • Acute Myeloid Leukemia
    • +9 more
    • umbilical cord stem cells
    • San Francisco, California
      University of California, San Francisco
    Aug 13, 2013

    Lymphoma, Mantle-Cell Trial in Vicenza (Rituximab, Bendamustine, Cytarabine)

    Completed
    • Lymphoma, Mantle-Cell
    • Rituximab, Bendamustine, Cytarabine
    • Vicenza, VI, Italy
      Department of Hematology, Ospedale San Bortolo
    Sep 25, 2012

    Lymphoma, Mantle-Cell Trial in Paris, Munich, Warszawa (Rituximab, Cyclophosphamide, Doxorubicin)

    Unknown status
    • Lymphoma, Mantle-Cell
    • Paris, France
    • +2 more
    Sep 7, 2012

    Lymphoma, Mantle-Cell Trial in Houston (Yttrium-ibritumomab (Zevalin), Rituximab)

    Completed
    • Lymphoma, Mantle-Cell
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 31, 2011

    Lymphoma, Mantle-Cell Trial in Milano, Reggio Di Calabria (Combination of dexamethasone, ofatumumab and bendamustine)

    Unknown status
    • Lymphoma, Mantle-Cell
    • Combination of dexamethasone, ofatumumab and bendamustine
    • Milano, Italy
    • +1 more
    Sep 12, 2011

    Lymphoma, Mantle-Cell Trial in Vienna (bortezomib, rituximab, dexamethasone)

    Unknown status
    • Lymphoma, Mantle-Cell
    • Vienna, Austria
      Medical University Vienna, Dept. of Medicine I, Clinical Divisio
    Oct 17, 2006